Ugnay, Helen U.
HRN: 22-50-67 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/03/2023
CEFUROXIME 750MG (VIAL)
02/03/2023
02/10/2023
IV
750mg
Q8h
Infected Wound
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: No Wrong Duration Wrong Duration
Overall appropriateness: No Wrong Duration